CSDX · Cs Diagnostics Corp. · Financials
The latest filing states the doubt was alleviated.
“These conditions initially raised substantial doubt about the Company’s ability to continue as a going concern within one year from the date the financial statements are issued. ... Accordingly, management has determined that substantial doubt about the Company’s ability to continue as a going concern has been alleviated.”View the 10-K filed Apr 15, 2026
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | FY2024 |
|---|---|
| $761 |
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.